A new clinical trial led by the Cleveland Clinic is evaluating a ketogenic nutrition-based approach using Ren-Nu™ and KetoCitra® to address the metabolic drivers of Autosomal Dominant Polycystic Kidney Disease (ADPKD). The study will assess safety, feasibility, and metabolic and...
FOR IMMEDIATE RELEASE SANTA BARBARA, CA – Santa Barbara Nutrients (SBN) is pleased to announce the first interim results from an ongoing clinical trial to study the safety and efficacy of SBN’s medical food KetoCitra® in combination with education on...
FOR IMMEDIATE RELEASE Santa Barbara Nutrients Announces Publication of Peer-Reviewed Study Reporting Real-World Outcomes of Ren-Nu™ Program for Polycystic Kidney Disease Santa Barbara, CA — January 21, 2026 — Santa Barbara Nutrients, Inc., a science-driven biotechnology and nutrition company focused on...
FOR IMMEDIATE RELEASE Santa Barbara Nutrients Welcomes Renowned Psychiatrist-Scientist Dr. Guido K.W. Frank to Advisory Board SANTA BARBARA, Calif. — January 27, 2026 — Santa Barbara Nutrients (SBN), a science-driven company dedicated to advancing metabolic health solutions, today announced the...
Polycystic Kidney Disease expert from Johns Hopkins brings deep clinical and research experience SANTA BARBARA, CA, UNITED STATES, August 22, 2025 -- Santa Barbara Nutrients (SBN), a leader in science-based therapeutic and nutrition solutions for kidney health, is proud to...
